PARENTI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.738
EU - Europa 3.028
AS - Asia 2.752
SA - Sud America 384
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 81
OC - Oceania 8
Totale 13.110
Nazione #
US - Stati Uniti d'America 6.582
SG - Singapore 823
IT - Italia 809
GB - Regno Unito 738
CN - Cina 663
VN - Vietnam 331
HK - Hong Kong 315
DE - Germania 307
BR - Brasile 276
SE - Svezia 253
FR - Francia 225
BD - Bangladesh 144
FI - Finlandia 133
RU - Federazione Russa 122
PL - Polonia 83
CA - Canada 78
KR - Corea 77
UA - Ucraina 77
TR - Turchia 72
IN - India 67
ID - Indonesia 65
IE - Irlanda 55
BG - Bulgaria 36
MX - Messico 34
AR - Argentina 33
JP - Giappone 31
ZA - Sudafrica 30
IQ - Iraq 29
NL - Olanda 29
BE - Belgio 23
AE - Emirati Arabi Uniti 19
CL - Cile 19
CO - Colombia 19
ES - Italia 17
PK - Pakistan 17
CH - Svizzera 16
CZ - Repubblica Ceca 15
LT - Lituania 14
SA - Arabia Saudita 14
SI - Slovenia 14
EC - Ecuador 13
MY - Malesia 13
RO - Romania 11
AT - Austria 10
UZ - Uzbekistan 10
CR - Costa Rica 9
MA - Marocco 9
KE - Kenya 8
PR - Porto Rico 8
EG - Egitto 7
MD - Moldavia 7
NP - Nepal 7
PE - Perù 7
VE - Venezuela 7
AU - Australia 6
JO - Giordania 6
BO - Bolivia 5
DK - Danimarca 5
DZ - Algeria 5
EU - Europa 5
GR - Grecia 5
PY - Paraguay 5
AZ - Azerbaigian 4
EE - Estonia 4
ET - Etiopia 4
IL - Israele 4
IR - Iran 4
LB - Libano 4
PA - Panama 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
GH - Ghana 3
GT - Guatemala 3
HN - Honduras 3
NI - Nicaragua 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
GE - Georgia 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
MN - Mongolia 2
NA - Namibia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
Totale 12.980
Città #
Ashburn 740
Singapore 517
Santa Clara 516
Southend 477
Fairfield 476
San Jose 381
Chandler 320
Hong Kong 305
Woodbridge 275
Council Bluffs 241
Houston 229
Seattle 192
Ann Arbor 190
Cambridge 167
Wilmington 151
Beijing 146
Hefei 142
Nyköping 141
New York 140
Dearborn 137
Modena 133
Chicago 131
Los Angeles 125
London 121
Jacksonville 118
Helsinki 96
Ho Chi Minh City 95
Hanoi 77
Seoul 74
Kraków 64
Milan 64
Dublin 54
The Dalles 54
Jakarta 48
San Diego 46
Salt Lake City 45
Munich 43
Bologna 40
Dallas 39
Izmir 38
Princeton 38
Reggio Emilia 38
Buffalo 36
Moscow 35
Shanghai 35
Sofia 35
Fremont 34
Bremen 33
Boardman 32
Lauterbourg 32
Frankfurt am Main 30
Denver 29
Atlanta 26
Eugene 26
São Paulo 25
Tokyo 25
Redwood City 24
Tampa 22
Phoenix 21
Brussels 20
Orem 20
Rome 20
San Giuliano Milanese 19
Toronto 19
Columbus 18
Da Nang 18
Falls Church 18
Montreal 18
Nuremberg 18
Dong Ket 17
Warsaw 17
Elk Grove Village 16
Miami 16
Brooklyn 15
Des Moines 15
Johannesburg 15
Baghdad 14
Haiphong 14
Lancaster 14
Mexico City 14
Sterling 14
Turku 14
Düsseldorf 13
Naples 13
Amsterdam 12
Charlotte 12
Belo Horizonte 11
Boston 11
Philadelphia 11
Poplar 11
San Francisco 11
Guangzhou 10
Lawrence 10
Palermo 10
Paris 10
Parma 10
Rio de Janeiro 10
Florence 9
Formigine 9
Portsmouth 9
Totale 8.539
Nome #
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 526
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 452
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 433
The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors 428
TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation 424
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 424
Loss of zfp36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1 417
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 400
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 393
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 385
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 380
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 378
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 362
ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+ Hematopoietic Stem Cells by Interfering with Stat5b Pathway. 343
Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors. 343
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 336
The Orosomucoid1 protein is involved in the vitamin D – mediated macrophage de-activation process 334
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 321
Physiological expression of miR-130a during differentiation of CD34+ human hematopoietic stem cells results in the inhibition of monocyte differentiation 315
Alpha – 1 – acid glycoprotein-A is a new VDR transcriptional target involved in monocyte differentiation and activation processes. 314
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 309
Promoter Methylation Leads to Decreased ZFP36 Expression and Deregulated NLRP3 Inflammasome Activation in Psoriatic Fibroblasts 305
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 291
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 289
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 288
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 286
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 285
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 273
Magnesium is a key regulator of the balance between osteoclast and osteoblast differentiation in the presence of vitamin D 3 273
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 271
Characterization of new ATM deletion associated with hereditary breast cancer 267
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 263
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 260
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 255
Chemoprevention of colorectal cancer 247
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 231
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 223
Magnesium favors the capacity of vitamin d3 to induce the monocyte differentiation of u937 cells 221
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 189
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms 172
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis 152
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model 52
Totale 13.110
Categoria #
all - tutte 49.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022689 0 0 0 35 33 58 61 68 91 82 149 112
2022/2023995 114 121 79 95 103 110 27 91 156 17 35 47
2023/2024654 35 27 58 72 125 60 55 91 9 12 38 72
2024/20252.213 71 22 32 122 461 331 182 143 204 115 255 275
2025/20264.159 285 100 263 478 734 266 532 178 425 396 298 204
2026/2027991 128 236 256 371 0 0 0 0 0 0 0 0
Totale 13.110